Effects of low-frequency rTMS combined with risperidone on the gut microbiome in hospitalized patients with chronic schizophrenia

Rui Li,Rui Fu,Zhi-Quan Cui,Lin Guo,Yi-Huan Chen,Jie Bai,Jia-Bin Yang,Qing-Rong Tan,Zheng-Wu Peng,Zhi-quan Cui,Yi-huan Chen,Jia-bin Yang,Qing-rong Tan,Zheng-wu Peng
DOI: https://doi.org/10.1016/j.brainres.2023.148539
IF: 3.61
2023-08-23
Brain Research
Abstract:Repetitive transcranial magnetic stimulation (rTMS) has been widely used in treating schizophrenia (SCH). However, the effects of the low frequency of rTMS combined with antipsychotics on the gut microbiome in chronic SCH have been poorly investigated. In the present study, psychiatric symptoms were assessed and the stool samples obtained from 33 adult patients with chronic SCH (at baseline phase), 27 after 2 weeks of treatment (rTMS combined with risperidone, SCH-2W), and 37 healthy controls (HC) were analyzed by 16S rRNA gene sequencing. We found that the reduction of phylum Proteobacteria , family Enterobacteriaceae and genera Escherichia-Shigella as well as the increase of genera norank_f_Lachnospiraceae might be related to the antipsychotic effect of rTMS combined with risperidone. These findings indicate that the brain-gut-microbiota axis might be involved in the therapeutic effect of rTMS combined with antipsychotic drugs.
neurosciences
What problem does this paper attempt to address?